Next Article in Journal
JNK Pathway Mediates Low Oxygen Level Induced Epithelial–Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer Cells
Previous Article in Journal
Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
Open AccessArticle

MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer

1
Laboratory of Experimental and Translational Oncology, Pathology, Department of Oncology, Microbiology and Immunology, Faculty of Sciences and Medicine, University of Fribourg, 1700 Fribourg, Switzerland
2
Laboratory for Translational Breast Cancer Research, KU Leuven, 3001 Leuven, Belgium
3
Institute of Pathology, University of Bern, 3008 Bern, Switzerland
4
Tumor Ecology Laboratory, Pathology, Department of Oncology, Microbiology and Immunology, Faculty of Science and Medicine, University of Fribourg, 1700 Fribourg, Switzerland
*
Authors to whom correspondence should be addressed.
These authors contributed equally to the work.
Cancers 2020, 12(1), 223; https://doi.org/10.3390/cancers12010223
Received: 31 July 2019 / Revised: 20 December 2019 / Accepted: 4 January 2020 / Published: 16 January 2020
Membrane-associated guanylate kinase (MAGUK) with inverted domain structure-1 (MAGI1) is an intracellular adaptor protein that stabilizes epithelial junctions consistent with a tumor suppressive function in several cancers of epithelial origin. Here we report, based on experimental results and human breast cancer (BC) patients’ gene expression data, that MAGI1 is highly expressed and acts as tumor suppressor in estrogen receptor (ER)+/HER2 but not in HER2+ or triple negative breast cancer (TNBC). Within the ER+/HER2 subset, high MAGI1 expression associates with ESR1 and luminal genes GATA3 and FOXA1 expression and better prognosis, while low MAGI1 levels correlates with higher histological grade, more aggressive phenotype and worse prognosis. Experimentally, MAGI1 downregulation in the ER+ human BC cells MCF7 impairs ER expression and signaling, promotes cell proliferation, and reduces apoptosis and epithelial differentiation. MAGI1 downregulation in the ER+ murine BC cell line 67NR accelerates primary tumor growth and enhances experimental lung metastasis formation. MAGI1 expression is upregulated by estrogen/ER, downregulated by prostaglandin E2/COX-2axis, and negatively correlates with inflammation in ER+/HER2 BC patients. Taken together, we show that MAGI1 is a new potential tumor suppressor in ER+/HER2 breast cancer with possible prognostic value for the identification of patients at high-risk of relapse within this subset. View Full-Text
Keywords: breast cancer; MAGI1; prognosis; stratification; estrogen receptor; recurrence; inflammation; COX-2; metastasis breast cancer; MAGI1; prognosis; stratification; estrogen receptor; recurrence; inflammation; COX-2; metastasis
Show Figures

Figure 1

MDPI and ACS Style

Alday-Parejo, B.; Richard, F.; Wörthmüller, J.; Rau, T.; Galván, J.A.; Desmedt, C.; Santamaria-Martinez, A.; Rüegg, C. MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer. Cancers 2020, 12, 223.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop